HealthStream (NASDAQ:HSTM) Stock: Insider Michael Manning Collier Sells 21,300 Shares

HealthStream, Inc. (NASDAQ:HSTM) EVP Michael Manning Collier sold 21,300 shares of the stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $29.97, for a total transaction of $638,361.00. Following the transaction, the executive vice president directly owned 59,260 shares of the company’s stock, valued at $1,776,022.20. This represents a 26.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

HealthStream Stock Down 2.4%

Shares of NASDAQ:HSTM opened at $28.89 on Friday. The company has a market cap of $844.17 million, a P/E ratio of 41.27, a PEG ratio of 3.01 and a beta of 0.45. HealthStream, Inc. has a 52 week low of $19.50 and a 52 week high of $35.60. The company has a 50-day moving average price of $31.20 and a 200 day moving average price of $25.83.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings data on Monday, November 2nd. The technology company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. HealthStream had a return on equity of 6.37% and a net margin of 6.25%. The company had revenue of $83.31 million for the quarter, compared to analyst estimates of $82.24 million. Analysts expect that HealthStream, Inc. will post 0.80 EPS for the current year.

HealthStream Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Monday, November 16th will be issued a $0.0350 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. HealthStream’s dividend payout ratio (DPR) is currently 20.00%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HSTM. Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. Craig Hallum downgraded HealthStream from a “buy” rating to a “hold” rating and set a $40.00 target price for the company. in a report on Tuesday, November 3rd. Weiss Ratings upgraded shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Freedom Capital upgraded shares of HealthStream to a “hold” rating in a research report on Tuesday, October 13th. Finally, Wall Street Zen cut shares of HealthStream from a “buy” rating to a “hold” rating in a research note on Sunday. One investment analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $36.00.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in HSTM. BlackRock Inc. purchased a new stake in shares of HealthStream during the 2nd quarter worth approximately $111,184,000. Dimensional Fund Advisors LP grew its holdings in shares of HealthStream by 6.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock worth $30,156,000 after acquiring an additional 87,177 shares during the period. Copeland Capital Management LLC increased its stake in HealthStream by 43.8% in the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares in the last quarter. Renaissance Technologies LLC increased its stake in HealthStream by 0.5% in the 1st quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock valued at $9,896,000 after purchasing an additional 2,380 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in HealthStream by 21.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock valued at $7,827,000 after purchasing an additional 65,806 shares in the last quarter. 69.58% of the stock is owned by hedge funds and other institutional investors.

More HealthStream News

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.